MedTrace Logo

A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

NCT06547359 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2024-11-14

No results posted yet for this study

Summary

A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

Conditions

  • Healthy Volunteers

Interventions

DRUG

Obicetrapib 10mg

tablets

DRUG

Ezetimibe 10mg

tablets

Sponsors & Collaborators

  • Pharma Medica Research, Inc.

    collaborator INDUSTRY

  • NewAmsterdam Pharma

    lead INDUSTRY

Principal Investigators

  • Mark M Feldman · Pharma Medica Research, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2024-11-12
Completion
2024-11-12
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06547359 on ClinicalTrials.gov